Table 2.

Association of PET amyloid markers and NS estimates with MRI-derived markers of CeVD and neurodegeneration (Spearman ρ, p value < 0.1; * < 0.05; ** < 0.01, *** < 0.001)

All subjects (n = 172)	SUVr	NS (SN)	SAβL(SN)	NS (cGAN)	SAβL(cGAN)
Number of CMBs	− 0.02	− 0.09	0.02	− 0.15*	0.02
Number of cortical infarcts	− 0.17*	− 0.22**	− 0.11	− 0.08	− 0.15 .
Number of lacunes	− 0.18*	− 0.25***	− 0.12	− 0.15.	− 0.13 .
WMH	4.58E-03	− 0.2**	4.79E-02	− 0.09	0.02
Hippocampal volume	− 0.38***	0.3***	− 0.43***	0.13 .	− 0.38***
Cortical atrophy grade	0.10	− 0.47***	0.19*	− 0.20**	0.13 .
No CeVD (n = 21)
Hippocampal volume	− 0.67**	0.53*	− 0.69***	0.33	− 0.71***
Cortical atrophy grade	0.43 *	− 0.79***	0.44*	− 0.59**	0.44*
SUVr < 1.2 (n = 82)
Number of CMBs	− 0.12	0.034	− 0.14	− 0.11	− 0.02
Number of cortical infarcts	− 0.33**	− 0.32**	− 0.13	− 0.12	− 0.27*
Number of lacunes	− 0.37***	− 0.39***	− 0.13	− 0.23*	− 0.18 .
WMH	− 0.12	− 0.20 .	0.04	− 0.05	− 0.09
Hippocampal volume	0.19.	0.34**	− 0.02	0.06	0.22*
Cortical atrophy grade	− 0.26*	− 0.51***	0.06	− 0.11	− 0.21 .